Insulet (PODD) Stock Price Today, Pre-Market & After-Hours

Data

Supercharts

Legend

Watchlist

Insulet Corporation

PODD

Nasdaq

Health Technology

Medical Specialties

147.48

USD

-2.48

-1.65%

Closed: 09-04 20:00 (UTC+0)

147.48

USD

+1.11

+0.75%

After Hours: 09-05 00:00 (UTC+0)

PODD Key Statistics

High

150.56

Open

149.32

Volume

1.05M

Low

145.42

Prev. Close

149.96

Trading Value

155.81M

52-Week High

354.88

Relative Volume

0.97

Amplitude (%)

3.43%

52-Week Low

126.40

Turnover Rate

1.53%

Market Cap

10.22B

P/E Ratio (TTM)

29.24

P/E Ratio (Annual)

42.017

P/B Ratio

7.19

P/S Ratio

3.35

Earnings Per Share (EPS)

5.044

Dividend (TTM)

Dividend Yield

0.00%

Shares Outstanding

69.35M

Currency Unit

USD

PODD Price Performance

7 day

30 day

90 day

180 day

Year to date

1 Year

PODD Money Flow Distribution

PODD Daily Short Sale Volume

PODD Short Interest History

PODD Stock Snapshot

As of 2026-09-05, the Insulet Corporation (PODD) stock price today is 147.48. Based on this price, the company has a market capitalization of $10.22B, with a P/E ratio of 29.24. On 2026-09-05, PODD traded between 145.42 and 150.56. Today’s stock price is 1.42% above the daily low and 2.05% below the daily high, placing PODD near the middle of its most recent trading range. Trading volume currently stands at 1.05M, compared with an average daily volume of 1.09M. This suggests that trading activity is roughly in line with its usual level than usual. Over the past year, Insulet Corporation shares have traded between 126.40 and 354.88. At today’s price, PODD is 16.68% above its 52-week low and 58.44% below its 52-week high.

PODD Related News

About PODD

Company Name

Insulet Corporation

Sector

Health Technology

Industry

Medical Specialties

Exchanges

Nasdaq

Number of Employees

5,400

Lot Size

100

Official Website

www.insulet.com

Currency Unit

USD

Insulet Corporation (PODD) is a medical-device company focused on making continuous subcutaneous insulin infusion easier for people with diabetes. Founded in 2000, the company developed the Omnipod system, which uses a small disposable insulin-infusion device that can be controlled through a smartphone to manage dosage. Omnipod received U.S. Food and Drug Administration approval in 2005, and more than 600,000 insulin-dependent diabetes patients now use the system worldwide.

Related Stocks

PODD FAQ

1.What is the live stock price of Insulet Corporation (PODD) today?

3. What were PODD’s trading range and trading volume on the most recent trading day?

What is the latest after-hours price of PODD?

7. What are PODD’s 52-week high and 52-week low?

9. What are PODD’s short sale volume and short interest?

11. What are Insulet Corporation’s P/E ratio and valuation metrics?

13. What were Insulet Corporation’s revenue and net income in the most recent quarter?

15.What is Insulet Corporation’s total number of shares outstanding?

17. Which exchange is Insulet Corporation listed on, and what sector and industry does it belong to?

19. What risks should investors consider before investing in PODD?

2.What is the ticker symbol for Insulet Corporation?

4. What is the latest pre-market price of PODD?

6.How has PODD’s stock price performed recently?

8. What is the current capital flow for PODD?

10. What is the current price of NVDA stock perps?

12. What is the market capitalization of Insulet Corporation?

14. What is Insulet Corporation’s earnings per share (EPS)?

16. Does Insulet Corporation pay dividends?

18. How many employees does Insulet Corporation have?